Connection
Philip Reigan to Ribosomal Protein S6 Kinases, 90-kDa
This is a "connection" page, showing publications Philip Reigan has written about Ribosomal Protein S6 Kinases, 90-kDa.
|
|
| |
Connection Strength |
|
 |
|
 |
| |
2.084 |
|
|
|
-
Casalvieri KA, Matheson CJ, Warfield BM, Backos DS, Reigan P. N-Substituted pyrrolopyrimidines and purines as p90 ribosomal S6 protein kinase-2 (RSK2) inhibitors. Bioorg Med Chem. 2021 07 01; 41:116220.
Score: 0.771
-
Casalvieri KA, Matheson CJ, Backos DS, Reigan P. Substituted pteridinones as p90 ribosomal S6 protein kinase (RSK) inhibitors: A structure-activity study. Bioorg Med Chem. 2020 03 01; 28(5):115303.
Score: 0.702
-
Casalvieri KA, Matheson CJ, Backos DS, Reigan P. Selective Targeting of RSK Isoforms in Cancer. Trends Cancer. 2017 04; 3(4):302-312.
Score: 0.579
-
Martinez EC, Passariello CL, Li J, Matheson CJ, Dodge-Kafka K, Reigan P, Kapiloff MS. RSK3: A regulator of pathological cardiac remodeling. IUBMB Life. 2015 May; 67(5):331-7.
Score: 0.032